Amlodipine Benzoate

CHEMBL4594262 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
531.0 g/mol
LogP
Phase
4

The benzoate salt form of amlodipine, a calcium channel blocker used to lower blood pressure by relaxing and widening blood vessels. It provides the same therapeutic effects as other amlodipine salts in treating hypertension.

Molekularmasse

531,0000 g/mol

TPSA

137,00 Ų

Therapeutische Bereiche

Wirkmechanismus

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl.O=C(O)c1ccccc1

InChI

InChI=1S/C20H25ClN2O5.C7H6O2/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21;8-7(9)6-4-2-1-3-5-6/h5-8,17,23H,4,9-11,22H2,1-3H3;1-5H,(H,8,9)

Molecular Formula

C27H31ClN2O7

HBD / HBA

3 / 9

Rotierbare Bindungen

11

Schwere Atome

37

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

The benzoate salt form of amlodipine, a calcium channel blocker used to lower blood pressure by relaxing and widening blood vessels. It provides the same therapeutic effects as other amlodipine salts in treating hypertension.

Blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac myocytes, reducing calcium influx during depolarization. This produces vasodilation, decreased myocardial contractility, and reduced heart rate.

Yes, Amlodipine Benzoate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594262. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 44481893. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.